Arturo Molina M.D., Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 61,028 shares at $55.74 ($3.4M) on 2025-03-13, disclosed to the SEC on 2025-03-14.
Open-market sale of $3.4M PTGX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.74 | 30,514 | $1.7M | 50.0% |
| 2 | $55.74 | 30,514 | $1.7M | 50.0% |
| Total | $55.74 avg | 61,028 | $3.4M | 100% |
| Filing → |
| PTGX | SELL | 2026-01-21 | $785K | — | Filing → |
| PTGX | SELL | 2025-11-19 | $460K | — | Filing → |
| PTGX | SELL | 2025-06-11 | $1.1M | — | Filing → |